Status:
COMPLETED
Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Moderate Traumatic Brain Injury
Testican-1
Eligibility:
All Genders
18+ years
Brief Summary
We aimed to determine if testican-1 and ubiquitin can serve as early indicators for diagnosing worsening clinical course (presence of intraparenchymal pathology) and mortality in patients with moderat...
Detailed Description
The study specifically included patients over 18 years of age with moderate TBI (GCS: 9-13) who provided informed consent. The control group consisted of healthy individuals without any disease who vo...
Eligibility Criteria
Inclusion
- being over 18 years old
- having a GCS score between 9 and 13
Exclusion
- under 18 years of age
- had missing data
- were pregnant
- had neurodegenerative disease
- had Central Nervous System (CNS) infection
- had cerebral palsy
- had penetrating head injury (by a cutting or piercing tool such as a firearm, knife, axe)
- patients with severe (GCS: 3-8) or mild (GCS: 14-15) TBI
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT06537713
Start Date
October 1 2020
End Date
April 30 2021
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni SUltan Suleyman Training and Research Hospital
Istanbul, Küçükçekmece, Turkey (Türkiye), 34303